Laith Al Momani1, Mohammad Alomari2, Hunter Bratton3, Boonphiphop Boonpherg1, Tyler Aasen4, Bara El Kurdi1, Mark Young4. 1. Department of Internal Medicine, East Tennessee State University, Johnson City, TN, USA. 2. Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA. 3. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA. 4. Department of Gastroenterology, East Tennessee State University, Johnson City, TN, USA.
Abstract
BACKGROUND: Capsule endoscopy (CE) is a non-invasive imaging modality designed to evaluate various small bowel pathologies. Failure to reach the cecum within the battery lifespan, termed incomplete examination, may result in inadequate testing and possibly delayed therapy. Several studies have attempted to evaluate the association between CE completion and opioid use. However, their results are conflicting. The aim of this meta-analysis is to evaluate the previously published literature on the association between opioid use and CE completion. METHODS: We performed a comprehensive literature search in PubMed, PubMed Central, Embase, and ScienceDirect databases from inception through June 1, 2018, to identify all studies that evaluated the association between CE completion and opioid use. We included studies that presented an odds ratio (OR) with a 95% confidence interval (CI) or presented the data sufficient to calculate the OR with a 95% CI. Statistical analysis was performed using the comprehensive meta-analysis (CMA), version 3 software. RESULTS: Five studies with a total of 1,614 patients undergoing CE in the inpatient (IP) and outpatient (OP) setting were included in this study, 349 of which had an incomplete CE (21.6%). The pooled OR for CE completion is 0.50 (95% CI: 0.38-0.66, I2=36.9%) in opioid users compared to non-users. No publication bias was found using Egger's regression test. CONCLUSIONS: Our results indicate that patients on opioids are significantly less likely to have a complete CE examination compared to non-users. To our knowledge, this study represents the first meta-analysis to assess this association. 2020 Translational Gastroenterology and Hepatology. All rights reserved.
BACKGROUND: Capsule endoscopy (CE) is a non-invasive imaging modality designed to evaluate various small bowel pathologies. Failure to reach the cecum within the battery lifespan, termed incomplete examination, may result in inadequate testing and possibly delayed therapy. Several studies have attempted to evaluate the association between CE completion and opioid use. However, their results are conflicting. The aim of this meta-analysis is to evaluate the previously published literature on the association between opioid use and CE completion. METHODS: We performed a comprehensive literature search in PubMed, PubMed Central, Embase, and ScienceDirect databases from inception through June 1, 2018, to identify all studies that evaluated the association between CE completion and opioid use. We included studies that presented an odds ratio (OR) with a 95% confidence interval (CI) or presented the data sufficient to calculate the OR with a 95% CI. Statistical analysis was performed using the comprehensive meta-analysis (CMA), version 3 software. RESULTS: Five studies with a total of 1,614 patients undergoing CE in the inpatient (IP) and outpatient (OP) setting were included in this study, 349 of which had an incomplete CE (21.6%). The pooled OR for CE completion is 0.50 (95% CI: 0.38-0.66, I2=36.9%) in opioid users compared to non-users. No publication bias was found using Egger's regression test. CONCLUSIONS: Our results indicate that patients on opioids are significantly less likely to have a complete CE examination compared to non-users. To our knowledge, this study represents the first meta-analysis to assess this association. 2020 Translational Gastroenterology and Hepatology. All rights reserved.
Entities:
Keywords:
Bleeding; capsule endoscopy (CE); narcotics; opioid; small intestine
Authors: Vladimir M Kushnir; Pavan Bhat; Reena V Chokshi; Alexander Lee; Brian B Borg; Chandra Prakash Gyawali; Gregory S Sayuk Journal: Dig Liver Dis Date: 2013-09-06 Impact factor: 4.088
Authors: Emanuele Rondonotti; Juan Manuel Herrerias; Marco Pennazio; Angel Caunedo; Miguel Mascarenhas-Saraiva; Roberto de Franchis Journal: Gastrointest Endosc Date: 2005-11 Impact factor: 9.427
Authors: Adam A Bailey; Henry S Debinski; Mark N Appleyard; Matthew L Remedios; Judy E Hooper; Alissa J Walsh; Warwick S Selby Journal: Am J Gastroenterol Date: 2006-10 Impact factor: 10.864
Authors: J H Cheon; Y-S Kim; I-S Lee; D K Chang; J-K Ryu; K J Lee; J-S Moon; C H Park; J-O Kim; K-N Shim; C H Choi; D Y Cheung; B I Jang; G-S Seo; H-J Chun; M-G Choi Journal: Endoscopy Date: 2007-12 Impact factor: 10.093